Classified Human Subjects Research Continues at DOE
A dozen classified programs that involved research on human subjects were underway last year at the Department of Energy.
Human subjects research refers broadly to the collection of scientific data from human subjects. This could involve physical procedures that are performed on the subjects, or simply interviews and other forms of interaction with them.
Little information is publicly available about the latest DOE programs, most of which have opaque, non-descriptive names such as Tristan, Idaho Bailiff and Moose Drool. But a list of the classified programs was released this week under the Freedom of Information Act.
Human subjects research erupted into national controversy 25 years ago with reporting by Eileen Welsome of the Albuquerque Tribune on human radiation experiments that had been conducted by the Atomic Energy Commission, many of which were performed without the consent of the subjects. A presidential advisory committee was convened to document the record and to recommend appropriate policy responses.
In 2016, the Department of Energy issued updated guidelines on human subjects research, which included a requirement to produce a listing of all classified projects involving human subjects. It is that listing that has now been released.
“Research using human subjects provides important medical and scientific benefits to individuals and to society. The need for this research does not, however, outweigh the need to protect individual rights and interests,” according to the 2016 DOE guidance on protection of human subjects in classified research.
An extravagantly horrific example of fictional human subject research was imagined by Lindsay Anderson in his 1973 film O Lucky Man! which captured the zeitgeist for a moment.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.